Achieve Life Sciences Inc expected to post a loss of 36 cents a share - Earnings Preview

Achieve Life Sciences

05/05/2025 12:10

Achieve Life Sciences Inc ACHV.OQ ACHV.O is expected to show no change in quarterly revenue when it reports  results on May 7 (estimated) for the period ending March 31 2025

​LSEG's mean analyst estimate for Achieve Life Sciences Inc is for a loss of 36 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Achieve Life Sciences Inc is $12.00​, above​ its last closing price of $2.57. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.36
-0.32
-0.36
Missed
-12.5
Sep. 30 2024
-0.28
-0.26
-0.36
Missed
-37.7
Jun. 30 2024
-0.23
-0.23
-0.25
Missed
-7.9​
Mar. 31 2024
-0.25
-0.24
-0.26
Missed
-6.6
​​Dec. 31 2023
-0.31
-0.31
-0.26
Beat
17.3
Sep. 30 2023
-0.37
-0.38
-0.34
Beat
10.2​
Jun. 30 2023
-0.41
-0.42
-0.43
Missed
-2
Mar. 31 2023
-0.68
-0.69
-0.50
Beat
27.1

This summary was machine generated May 5 at 11:10 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)